Chinanews client, September 21. The China Securities Regulatory Commission announced on the evening of September 21 that recently, the stock prices of "Tianshan Bio" and other stocks fluctuate abnormally in the short term, and the market is paying close attention.

Recently, the CSRC has filed an investigation on the abnormal transaction.

In the next step, we will deal with it in accordance with the law on the basis of a comprehensive investigation to effectively maintain the healthy and stable development of the market.